Abstract:Over the years development of selective estrogen receptor (ER) ligands has been of great concern to researchers involved in the chemistry and pharmacology of anticancer drugs, resulting in numerous synthesized selective ER subtype inhibitors. In this work, a data set of 82 ER ligands with ERα and ERβ inhibitory activities was built, and quantitative structure-activity relationship (QSAR) methods based on the two linear (multiple linear regression, MLR, partial least squares regression, PLSR) and a nonlinear statistical method (Bayesian regularized neural network, BRNN) were applied to investigate the potential relationship of molecular structural features related to the activity and selectivity of these ligands. For ERα and ERβ, the performances of the MLR and PLSR models are superior to the BRNN model, giving more reasonable statistical properties (ERα: for MLR, Rtr2 = 0.72, Qte2 = 0.63; for PLSR, Rtr2 = 0.92, Qte2 = 0.84. ERβ: for MLR, Rtr2 = 0.75, Qte2 = 0.75; for PLSR, Rtr2 = 0.98, Qte2 = 0.80). The MLR method is also more powerful than other two methods for generating the subtype selectivity models, resulting in Rtr2 = 0.74 and Qte2 = 0.80. In addition, the molecular docking method was also used to explore the possible binding modes of the ligands and a relationship between the 3D-binding modes and the 2D-molecular structural features of ligands was further explored. The results show that the binding affinity strength for both ERα and ERβ is more correlated with the atom fragment type, polarity, electronegativites and hydrophobicity. The substitutent in position 8 of the naphthalene or the quinoline plane and the space orientation of these two planes contribute the most to the subtype selectivity on the basis of similar hydrogen bond interactions between binding ligands and both ER subtypes. The QSAR models built together with the docking procedure should be of great advantage for screening and designing ER ligands with improved affinity and subtype selectivity property.

Discovery of natural estrogen receptor modulators with structure-based virtual screening.

Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy

3d-Qsar And Docking Studies Of Estrogen Compounds Based On Estrogen Receptor Beta

Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches.

Discovery of Potent Ligands for Estrogen Receptor β by Structure-Based Virtual Screening

Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships.

Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.

Combining Docking and Comparative Molecular Similarity Indices Analysis (comsia) to Predict Estrogen Activity and Probe Molecular Mechanisms of Estrogen Activity for Estrogen Compounds

Selective Ligands of Estrogen Receptor Β Discovered Using Pharmacophore Mapping and Structure-Based Virtual Screening.

Discovery of New Estrogen-Related Receptor α Agonists via a Combination Strategy Based on Shape Screening and Ensemble Docking

Discovery of Estrogen Receptor Modulators: a Review of Virtual Screening and SAR Efforts

Identification and Structure-Activity Relationships of a Novel Series of Estrogen Receptor Ligands Based on 7-Thiabicyclo[2.2.1]hept-2-ene-7-oxide.

Novel Estrogen Receptor Ligands and Their Structure-Activity Relationship Evaluated by Scintillation Proximity Assay for High-Throughput Screening

A multiplexed screening method for agonists and antagonists of the estrogen receptor protein

Structure-Activity Relationships For A Large Diverse Set Of Natural, Synthetic, And Environmental Estrogens

Design, Synthesis and Biological Evaluation of Novel 2-Methoxyestradiol Analogs As Dual Selective Estrogen Receptor Modulators (serms) and Antiangiogenic Agents

Discovery of Natural Products As Novel and Potent FXR Antagonists by Virtual Screening.

In Silico Prediction of Estrogen Receptor Subtype Binding Affinity and Selectivity Using 3D-QSAR and Molecular Docking

In Silico Prediction of Estrogen Receptor Subtype Binding Affinity and Selectivity Using Statistical Methods and Molecular Docking with 2-Arylnaphthalenes and 2-Arylquinolines

Identification of Active and Inactive Agonists/antagonists of Estrogen Receptor Based on Tox21 10K Compound Library: Binomial Analysis and Structure Alert.

Identification of 10-Dehydrooxyglycyuralin E As a Selective Human Estrogen Receptor Alpha Partial Agonist.